Malaria Patent Landscape 2009

Table of Contents

METHODOLOGY

INTRODUCTION

1. BRIEF OUTLINE OF THE MARKET

2. BRIEF OUTLINE OF THE PIPELINE

3. PROTECTION STRATEGIES

• 3.1. Evolution of patent filings over time
• 3.2. Priority filings
• 3.3.Extensions
• 3.4. Analysis of industrial filings over time
• 3.5. Study of the granting of US patents
• 3.6. Study of the granting of European patents
• 3.7. Study of the granting of Japanese patents
• 3.8. Evolution in the number of applicants
• 3.9. Breakdown by IPC codes

4. GENERAL ANALYSIS

• 4.1. Topology of patents in the sector
• 4.2. Analysis of the main applicants in the entire portfolio
• 4.3. Focus on the global strategy of the major industrial applicants
• 4.4.Collaborations
• 4.5. Citations between applicants
• 4.6. Most cited patents

5. FOCUS ON THE CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS

• 5.1. General analysis
• 5.1.1. Breakdown of patent filings over time
• 5.1.2. Focus on the main chemical classes
• 5.1.3. Focus on the other chemical classes
• 5.2.Applicants
• 5.2.1. Main applicants
• 5.2.2. Filings by main applicants over time
• 5.2.3. Topics protected for classified chemotherapeutic compounds
• 5.2.4. Topics protected for the other classified chemotherapeutic compounds
• 5.2.5. Emerging applicants
• 5.3. Inventors
• 5.3.1. Main inventors
• 5.3.2. Topics protected for classified chemotherapeutic compounds
• 5.3.3. Topics protected for other classified chemotherapeutic compounds
• 5.3.4. Research teams
• 5.3.5. Experts
• 5.3.6. Emerging inventors

6. FOCUS ON VACCINES

• 6.1. General analysis
• 6.1.1. Patent filings over time
• 6.1.2. Breakdown of patents by types of vaccines
• 6.2. Applicants
• 6.2.1. Main applicants
• 6.2.2. Topics protected
• 6.3. Inventors
• 6.3.1. Main inventors
• 6.3.2. Topics protected
• 6.3.3. Research teams
• 6.3.4. Experts

7. FOCUS ON DIAGNOSTIC

• 7.1. General analysis
• 7.1.1. Breakdown of patent filings over time
• 7.1.2. Breakdown of patents by diagnostic method
• 7.2. Applicants
• 7.2.1. Main applicants
• 7.2.2. Topics protected
• 7.2.3. Emerging applicants
• 7.3. Inventors
• 7.3.1. Main inventors
• 7.3.2. Topics protected
• 7.3.3. Research teams
• 7.3.4. Experts
• 7.3.5. Emerging inventors

8. FOCUS ON OTHER MALARIA PATENTS

• 8.1. General analysis
• 8.1.1. Breakdown of patent filings over time
• 8.2. Breakdown of other malaria patents
• 8.3. Applicants
• 8.3.1. Main applicants
• 8.3.2. Topics protected
• 8.4. Inventors
• 8.4.1. Main inventors
• 8.4.2. Topics protected

CONCLUSION

APPENDICES

• NUMBER OF PATENT FILINGS BY APPLICANTS
• NUMBER OF PATENT FILINGS OF COMPANIES PRESENT IN THE PIPELINE

Listo of Figures

• FIGURE 1 - NUMBER OF PEOPLE INFECTED BY MALARIA
• FIGURE 2 - LIFE CYCLE OF PLASMODIUM PARASITES
• FIGURE 3 - TREATMENTS UNDER DEVELOPMENT BY CLASS OF COMPOUNDS
• FIGURE 4 - EVOLUTION IN PATENT FILINGS
• FIGURE 5 - GEOGRAPHIC DISTRIBUTION OF PRIORITY FILINGS
• FIGURE 6 - GEOGRAPHIC DISTRIBUTION OF PRIORITY FILINGS/CLOSE-UP: EUROPE
• FIGURE 7 - GEOGRAPHIC DISTRIBUTION OF EXTENSIONS
• FIGURE 8 - EVOLUTION OF THE BREAKDOWN OF INDUSTRIAL FILINGS
• FIGURE 9 - EVOLUTION OF AVERAGE GRANT TIME FOR US PATENTS
• FIGURE 10 - EVOLUTION OF GRANTING OF US PATENTS
• FIGURE 11 - EVOLUTION OF GRANTING OF EUROPEAN PATENTS
• FIGURE 12 - EVOLUTION OF GRANTING OF EUROPEAN PATENTS
• FIGURE 13 - EVOLUTION OF GRANTING OF JAPANESE PATENTS
• FIGURE 14 - EVOLUTION OF GRANTING OF JAPANESE PATENTS
• FIGURE 15 - EVOLUTION OF THE NUMBER OF APPLICANTS
• FIGURE 16 - DISTRIBUTION OF THE 20 MAIN IPC CODES
• FIGURE 17 - BREAKDOWN OF THE PORTFOLIO BY APPLICATIONS
• FIGURE 18 - MAIN APPLICANTS IN THE ENTIRE PORTFOLIO
• FIGURE 19 - BREAKDOWN OF THE MAIN PATENT PORTFOLIO
• FIGURE 20 - EXTENSION POLICY FOR THE FIVE MAJOR INDUSTRIAL APPLICANTS
• FIGURE 21 - MAJOR COLLABORATIONS AND JOINT FILINGS
• FIGURE 22 - MAP OF CITATIONS BETWEEN APPLICANTS
• FIGURE 23 - BREAKDOWN OF PATENT FILINGS BY CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS OVER TIME
• FIGURE 24 - BREAKDOWN OF THE PORTFOLIO BY CHEMICAL CLASSES
• FIGURE 25 - BREAKDOWN OF THE OTHER CHEMICAL CLASSES
• FIGURE 26 - MAIN APPLICANTS OF CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
• FIGURE 27 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN APPLICANTS
• FIGURE 28- OTHER CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN APPLICANTS
• FIGURE 29 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN INVENTORS
• FIGURE 30 - OTHER CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN INVENTORS
• FIGURE 31 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN RESEARCH TEAMS
• FIGURE 32 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS EXPERTS
• FIGURE 33 - BREAKDOWN OF MALARIA VACCINE FILINGS OVER TIME
• FIGURE 34 - BREAKDOWN OF THE PORTFOLIO BY TYPES OF VACCINES
• FIGURE 35 - MAIN APPLICANTS OF MALARIA VACCINES
• FIGURE 36 - MAIN TYPES OF VACCINE BY MAIN APPLICANTS
• FIGURE 37 - TYPE OF VACCINES BY MAIN INVENTORS
• FIGURE 38 - MAIN MALARIA VACCINE RESEARCH TEAMS
• FIGURE 39 - LIST OF EXPERTS DEVELOPING MALARIA VACCINES
• FIGURE 40 - BREAKDOWN OF FILINGS ON MALARIAL DIAGNOSTICS OVER TIME
• FIGURE 41 - BREAKDOWN OF THE PORTFOLIO BY DIAGNOSTIC METHODS
• FIGURE 42 - MAIN APPLICANTS IN MALARIA DIAGNOSTICS
• FIGURE 43 - DIAGNOSTIC METHODS OF THE MAIN APPLICANTS
• FIGURE 44 - DIAGNOSTIC METHODS DEVELOPED BY THE MAIN INVENTORS
• FIGURE 45 - MAJOR COLLABORATIONS BETWEEN INVENTORS IN MALARIA DIAGNOSTICS
• FIGURE 46 - LIST OF EXPERTS IN THE FIELD OF MALARIA DIAGNOSTICS
• FIGURE 47 - BREAKDOWN OF PATENT FILINGS FOR OTHER MALARIA PATENTS OVER TIME
• FIGURE 48 - BREAKDOWN OF OTHER MALARIA PATENTS
• FIGURE 49 - MAIN APPLICANTS OF OTHER MALARIA PATENTS
• FIGURE 50 - BREAKDOWN OF OTHER MALARIA PATENTS BY MAIN APPLICANTS
• FIGURE 51 - OTHER MALARIA PATENTS FILED BY MAIN INVENTORS

List of Tables

• TABLE 1 - EVOLUTION OF PRIORITY FILINGS
• TABLE 2 - EVOLUTION OF EXTENSIONS
• TABLE 3 - DESCRIPTION OF THE 20 MAIN IPC CODES
• TABLE 4 - EVOLUTION OF THE 20 MAIN IPC CODES
• TABLE 5 - EXTENSION POLICY FOR THE FIVE MAJOR INDUSTRIAL APPLICANTS
• TABLE 6 - LIST OF THE MAIN CITED PATENTS PRESENT IN THIS PORTFOLIO
• TABLE 7 - LIST OF THE MAIN CITED PATENTS ABSENT OF THIS PORTFOLIO
• TABLE 8 - BREAKDOWN BY MAIN CHEMICAL CLASSES OVER TIME
• TABLE 9 - BREAKDOWN OF THE OTHER CHEMICAL CLASSES OVER TIME
• TABLE 10 - BREAKDOWN OF FILINGS BY MAIN APPLICANTS OVER TIME
• TABLE 11 - EMERGING APPLICANTS IN CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
• TABLE 12 - MAIN INVENTORS OF CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
• TABLE 13 - EMERGING INVENTORS OF CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
• TABLE 14 - BREAKDOWN BY TYPE OF VACCINE OVER TIME
• TABLE 15 - BREAKDOWN OF MALARIA VACCINE FILINGS BY MAIN APPLICANTS OVER TIME
• TABLE 16 - LIST OF MAIN INVENTORS DEVELOPING MALARIA VACCINES
• TABLE 17 - BREAKDOWN BY DIAGNOSTIC METHOD OVER TIME
• TABLE 18 - BREAKDOWN OF PATENTS FILED BY THE MAIN APPLICANTS IN MALARIA DIAGNOSTICS OVER TIME
• TABLE 19 - LIST OF EMERGING APPLICANTS IN THE FIELD OF MALARIA DIAGNOSTICS
• TABLE 20 - MAIN INVENTORS IN MALARIA DIAGNOSTICS
• TABLE 21 - LIST OF EMERGING INVENTORS IN THE FIELD OF MALARIA DIAGNOSTICS
• TABLE 22 - BREAKDOWN OF OTHER MALARIA PATENTS OVER TIME
• TABLE 23- BREAKDOWN OF FILINGS OF OTHER MALARIA PATENTS BY MAIN APPLICANTS OVER TIME
• TABLE 24 - LIST OF MAIN INVENTORS OF OTHER MALARIA TREATMENTS